In this episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, discusses: Principles for antiviral agent use in nonhospitalized patientsPreferred and alternative treatment optionsTreatment prioritization when there are logistical or supply constraintsOutpatient remdesivir usePINETREE data (adult patients)CARAVAN data (pediatric patients)FDA approval and treatment candidacyTherapeutic updatesIvermectin and the TOGETHER studyMonoclonal antibody use during current omicron eraPresenter: Sharon R. Lewin, AO, FRACP, PhD, FAHMSZDirector, The Peter Doherty Institute for Infection and ImmunityProfessor of Infectious DiseasesUniversity of MelbourneConsultant Infectious Diseases PhysicianAlfred Hospital and Royal Melbourne HospitalMelbourne, AustraliaReview the downloadable slideset at:https://bit.ly/3FXc90w Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related